IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $408 | -99.9% | 10,811 | -1.7% | 1.03% | -21.3% |
| Q3 2022 | $486,000 | +17.1% | 10,993 | -2.0% | 1.31% | +39.2% |
| Q2 2022 | $415,000 | -16.7% | 11,222 | +35.0% | 0.94% | +84.7% |
| Q3 2019 | $498,000 | -6.7% | 8,314 | 0.0% | 0.51% | -6.2% |
| Q2 2019 | $534,000 | -23.7% | 8,314 | -3.7% | 0.54% | -25.2% |
| Q1 2019 | $700,000 | +59.1% | 8,629 | +6.0% | 0.73% | +22.9% |
| Q4 2018 | $440,000 | +1417.2% | 8,140 | +1118.6% | 0.59% | +2017.9% |
| Q1 2018 | $29,000 | -86.1% | 668 | -83.9% | 0.03% | -86.7% |
| Q4 2017 | $209,000 | +40.3% | 4,154 | +41.1% | 0.21% | +24.3% |
| Q3 2017 | $149,000 | -15.8% | 2,944 | -15.4% | 0.17% | +87.8% |
| Q2 2017 | $177,000 | +28.3% | 3,481 | +1.2% | 0.09% | +18.4% |
| Q1 2017 | $138,000 | -86.2% | 3,440 | -78.7% | 0.08% | -78.1% |
| Q4 2015 | $1,001,000 | – | 16,161 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |